Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 508Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 328Paclitaxel 324Oxaliplatin 323Gemcitabine 320Docetaxel 310Fluorouracil 282Drug Therapy 243apatinib 242Bevacizumab 228camrelizumab 214Etoposide 200Irinotecan 175Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138Pemetrexed 136Cytarabine 136anlotinib 135toripalimab 130Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 116Radiosurgery 116

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Interventional × Thymopentin × Clear all
NCT00460681 2007-10-31

Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma

Fudan University

Phase 3 Unknown
220 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡